A review on triple-negative breast cancer and its potential treatment

A review on triple-negative breast cancer and its potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Dades bibliogràfiques
Autor principal:	Niasa, Jannatul Ferdous
Altres autors:	Chowdhury, Namara Mariam
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2023
Matèries:	TNBC HER-2 receptors Anti-cancer therapeutics Signaling pathways Breast > Cancer > Patients Breast > Cancer > Treatment
Accés en línia:	http://hdl.handle.net/10361/17766

Ítems similars

Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022)

Recent advancement on breast cancer detection and treatment
per: Rahman, Sanjida
Publicat: (2023)

Natural products and their combinatory effects in breast cancer treatment
per: Siddique, Md. Ayman
Publicat: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
per: Chakraborty, Anuradha
Publicat: (2024)

Breast cancer awareness seminars
per: Anwer Khan Modern Medical College
Publicat: (2016)

The impact of breast cancer on women’s lives in Bangladesh
per: Mobashera, Tayeeba Tum
Publicat: (2024)

Comparison of conventional doxorubicin with liposome encapsulated doxorubicin as a treatment of breast cancer-a review
per: Akter, Honufa
Publicat: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
per: Raihan, Dilraj
Publicat: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Pooled analysis of progression-free survival and overall survival in phase II clinical trials of breast cancer
per: Shobnam, Sohana
Publicat: (2024)

Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population
per: Parvin, Salma, et al.
Publicat: (2016)

Breast cancer therapy through Liposomal drug delivery system
per: Ome, Nusrat Jahan
Publicat: (2024)

Machine learning as an indicator for breast cancer prediction
per: Shadman, Tahsin Mohammed, et al.
Publicat: (2019)

Targeting DHFR in breast cancer: exploring expression patterns and identifying potential inhibitors through docking studies
per: Araf, Faiaz Fahim
Publicat: (2024)

Breast cancer in low-resource settings: Prioritizing the awareness and access programmes to overcome sociocultural and economic barriers for early detection and improved outcomes
per: Iqbal, Mohammad Shamim, et al.
Publicat: (2017)

A review on the potential of repurposing of metformin for colon cancer and breast cancer
per: Oishy, Jannatun Noor
Publicat: (2024)

Tamoxifen: The ideal post operative hormonal therapy to demote Ductal Carcinoma in Situ
per: Mirza, Maisa Tasnim
Publicat: (2023)

Role of toll-like receptors in cancer immunotherapy– a review
per: Khan, Rezia Nowrin
Publicat: (2021)

Pathway analysis of Disease-Gene associated network in the human breast cancer
per: Lamia
Publicat: (2020)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
per: Nuha, Nabiha Tahsin
Publicat: (2024)

Early detection of breast cancer using machine learning
per: Fuad, Wasi Mohammad
Publicat: (2019)

Breast cancer in South Asia: a Bangladeshi perspective
per: Hossain, Mohammad Sorowar, et al.
Publicat: (2017)

A review on potential of PARP inhibitors in the treatment of prostate cancer
per: Islam, Saidul
Publicat: (2022)

Palliative care services in cancer treatment: a study of the current scenario in Dhaka
per: Rahman, Qazi Ashrafur
Publicat: (2018)

Breast cancer prediction using different machine learning models
per: Khandker Al- Muhaimin, et al.
Publicat: (2020)

Current practice and approaches of immunotherapy in Cancer treatment
per: Khondokar, Faiza
Publicat: (2022)

Genetic innovations for breast cancer treatment : a review of gene therapy strategies and future implications
per: Hasan, Sakib
Publicat: (2024)

Potential phytochemicals and dietary components for the prevention and treatment of skin cancer: A review
per: Muntaha, Habibatul
Publicat: (2023)

Potential of liposomes for the treatment of lung cancer- a review
per: Mim, Shanzida
Publicat: (2023)

Role of statins as antagonists of SPARC in gastric cancer
per: Shahmat, Rad
Publicat: (2019)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
per: Karim, Azrin
Publicat: (2024)

Stem cells as therapeutic carrier in cancer treatment
per: Anika, Mysha Yeasmin
Publicat: (2022)

Microneedles in pain management of Cancer
per: Islam, Shafiqul
Publicat: (2022)

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)

A systematic review on the comparison of FOLFIRI and FOLFOX based chemotherapies in the treatment of metastatic colorectal Cancer
per: Islam, Nurjahan
Publicat: (2022)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
per: Hasan, Amit
Publicat: (2024)

A comprehensive review on drug repurposing in cancer treatment
per: Sarkar, Onusree
Publicat: (2024)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Machine learning In breast cancer prognosis and prediction
per: Chowdhury, Shah Abul Hasnat, et al.
Publicat: (2023)

Statistics and informatics in molecular cancer research